I-Entecavir CAS 142217-69-4 API Factory High Quality Anti-HBV
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leKhemikhali: Entecavir
CAS: 142217-69-4
Iyeza elilwa nentsholongwane esetyenziswa kunyango lwe-Hepatitis B Usulelo
Umgangatho ophezulu we-API, iMveliso yoRhwebo
Igama leMchiza | Entecavir |
Izithethantonye | I-2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-enye |
Inombolo yeCAS | 142217-69-4 |
Inombolo yeCAT | RF-API80 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | I-C12H15N5O3 |
Ubunzima beMolekyuli | 277.28 |
Indawo yokunyibilika | 249.0 ~ 252.0℃ |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo weCrystalline oMhlophe |
Ukuchongwa kwe-IR | I-spectrum yokufunxa i-infraed yesampuli yovavanyo kufuneka ihambelane nomgangatho wereferensi |
Ukuchongwa kwe-HPLC | Ixesha lokugcinwa kwesampulu yovavanyo lihambelana nelo lomgangatho wereferensi |
pH | 5.5~7.5 |
Ujikelezo oluKhethekileyo lwe-Optical | +24.0°-+28.0° (DMF: MeOH=1:1 C=1%) |
Izinto ezinxulumeneyo | |
Ukungcola ngokupheleleyo | ≤0.30% |
Ukungacoceki okuphezulu okukodwa | ≤0.10% |
I-Enantiomer | ≤0.20% |
Izinyibilikisi ezishiyekileyo | |
IMethanol | ≤0.30% |
Dichloromethane | ≤0.06% |
n-Hexane | ≤0.029% |
Tetrahydrofuran | ≤0.072% |
N, N-Dimethylformamide | ≤0.088% |
Toluene | ≤0.089% |
Isiqulatho samanzi | 5.8%~6.5% |
Intsalela kwi-Ignition | ≤0.10% |
Iintsimbi ezinzima | ≤20ppm |
Isivavanyi | 98.0% ~ 102.0% (C12H15N5O3 ibalwa ngesiseko se-anhydrous) |
Ubungakanani beNcam | D90: ≤100µm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | I-API, i-Antiviral drug esetyenziswa kunyango lwe-Hepatitis B Infection |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Entecavir isizukulwana esitsha se-guanine nucleoside analogues amayeza omlomo wonyango lwe-Hepatitis B Virus (HBV) usulelo, ngokukodwa kunyango lwezigulane zabantu abadala kunye nomsebenzi wokuphindaphinda kwentsholongwane kunye ne-serum transaminase yaqhubeka nokunyuka, okanye izicubu zesibindi ze-pathological activity of chronic hepatitis B. , okwangoku isezantsi intsholongwane ikhawuleza kakhulu kwaye inamandla, izinga lokuguquka kweyona nucleoside analogues.Idatha ibonisa ukuba ezahlukeneyo kwizigulane ezine-hepatitis B engapheliyo, kubandakanywa i-nucleoside naive kunye ne-nucleoside ephathwayo kunye nezigulane ze-cirrhosis yesibindi, ukusebenzisa iipilisi ze-entecavir kakuhle kunyango kunokulawula isifo ngokukhawuleza kwaye zifikeleleke ngokulula kunyango lwe-real end, i-virus ye-hepatitis B engenakulinganiswa;ngokubambelela kunyango, inxalenye enkulu yezigulane inokufikelelwa ekupheleni kolwaneliseko lonyango, oko kukuthi, ukuguqulwa kwe-antigen serology, ezinye izigulana zinokufikelela kunyango lwesiphelo, ezizezi, umphezulu we-antigen negative.